Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises AmSpec in connection with the acquisition of IIS
Mandate

Vinge advises AmSpec in connection with the acquisition of IIS

February 06, 2023 Employment and Benefits Intellectual Property M&A Real Estate and Construction IT, Telecommunications and Outsourcing Data protection and processing of personal data Commercial Agreements

AmSpec Group, Inc., together with its subsidiaries (“AmSpec”), is a multinational group of companies within inspection, analysis and testing of products in the energy- and agricultural industries.

IIS Independent Inspection Services AB (“IIS”) conducts testing, inspection and a range of support services to the energy- and agricultural sectors in the Nordic market. The company has its main laboratory in Gothenburg.

The acquisition of IIS strengthens AmSpec’s position in the European market in general, and in the Nordic market in particular.

Vinge’s team mainly consisted of Jonas Johansson, Viktor Lennartsson, Robin Sultani (M&A), Karin Gynnerstedt (employment), Christoffer Nordin (commercial agreements), Karolina Fuhrman (IT and GDPR), Arvid Axelryd (IP), Markus Bernander (real estate), Ottilia Pettersson and Ellinore Boström Andersson (project assistants).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025